Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
PharmaNutra S.p.A. (PHN)
Market Open
11 Aug, 15:30
XMIL
All
(5)
DE
(3)
GB
(1)
IT
(1)
XMUN
Primary
XFRA
XDUS
XMIL
CBOE
84.
70
-0.1
-0.1179%
545.72M
Market Cap
-
P/E Ratio
4.8%
Div Yield
7,283
Volume
-
Eps
84.8
Previous Close
Watching
Watch
Add Transaction
Day Range
84.3
86
Year Range
38.75
95.9
Want to track
PHN
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
Historical Data
PharmaNutra S.p.A. (PHN) Statistics
Valuation metrics
Market Cap
545.72M
Enterprise value
808M
Trailing P/E (ttm)
38.11
Forward P/E
28.14
PEG ratio
1.25
Price/Sales (ttm)
5.84
Price/Book (mrq)
10.86
Enterprise Value/Revenue
5.83
Enterprise Value/EBITDA
-175.77
Overview
Shares outstanding
9.58M
Float
3.28M
Shares short
-
% Held by insiders
0.65%
% Held by institutions
0.17%
Average volume (10 days)
7.07K
Average volume (90 days)
10.57K
Price summary
52-Week low
38.75
52-Week high
95.9
Beta
0.1
50-Day moving average
85.86
200-Day moving average
78.54
Dividends and splits
Forward annual dividend rate
4.8
Forward annual dividend yield
0.0556%
Trailing annual dividend rate
1.2
Trailing annual dividend yield
0.0142%
5-Year annual dividend yield
1.44%
Payout ratio
0.46
Dividend Date
6 May 2026
Ex-Dividend Date
4 May 2026
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.15%
Operating margin
-0.05%
Operational effectiveness
Return on assets
0.16%
Return on equity
0.31%
Income Statement
Revenue (ttm)
138.73M
Revenue per share (ttm)
14.48
Quarterly revenue growth (yoy)
0.24%
Gross profit (ttm)
70.76M
EBITDA
35.55M
Net income to common (ttm)
21.02M
Diluted EPS (ttm)
2.2
Quarterly earnings growth (yoy)
0.42%
Balance Sheet
Total cash (mrq)
29M
Total cash per share (mrq)
3.03
Total debt (mrq)
19.1M
Total Debt/Equity (mrq)
0.26
Current ratio (mrq)
2.38%
Book value per share (mrq)
7.78
Cash Flow
Cash flow statement
19.45M
Levered free cash flow (LFCF)
14.56M